Estrogen receptor α and β in the normal immune system and in lymphoid malignancies

Molecular and Cellular Endocrinology

Volumn 375, Issue 1-2, 2013, Pages 121-129

  Yakimchuk, Konstantin ^a   Jondal, Mikael ^a   Okret, Sam ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Estrogen receptors; Immune system; Lymphoma

Indexed keywords

DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

APOPTOSIS; AUTOIMMUNITY; BONE MARROW CELL; CELL PROLIFERATION; DRUG MECHANISM; ESTROGEN RECEPTOR ALPHA GENE; ESTROGEN RECEPTOR BETA GENE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; LYMPHOCYTE; LYMPHOID CELL; LYMPHOMA; MEDULLOBLASTOMA; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; T CELL LYMPHOMA;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; LYMPHOMA; MYELOID CELLS; PROTEIN ISOFORMS; SEX CHARACTERISTICS;

EID: 84879324042     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.05.016     Document Type: Review

References (151)

1. Acconcia F., Totta P., Ogawa S., Cardillo I., Inoue S., Leone S., Trentalance A., Muramatsu M., Marino M. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J. Cell Physiol. 2005, 203:193-201.
2. Al-Bader M., Al-Saji S., Ford C.H., Francis I., Al-Ayadhy B. Real-time PCR: detection of oestrogen receptor-alpha and -beta isoforms and variants in breast cancer. Anticancer Res. 2010, 30:4147-4156.
3. Antal M.C., Krust A., Chambon P., Mark M. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant. Proc. Natl. Acad. Sci. USA 2008, 105:2433-2438.
4. Ascenzi P., Bocedi A., Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol. Aspects Med. 2006, 27:299-402.
5. Bardin A., Hoffmann P., Boulle N., Katsaros D., Vignon F., Pujol P., Lazennec G. Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res. 2004, 64:5861-5869.
6. Bijlsma J.W., Masi A., Straub R.H., Lahita R., Cutolo M. Neuroendocrine immune system involvement in rheumatology. Ann. NY Acad. Sci. 2006, 1069:xviii-xxiv.
7. Blagosklonny M.V., Neckers L.M. Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Cancer Lett. 1994, 76:81-86.
8. Bollig A., Miksicek R.J. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol. Endocrinol. 2000, 14:634-649.
9. Bouman A., Heineman M.J., Faas M.M. Sex hormones and the immune response in humans. Hum. Reprod. Update 2005, 11:411-423.
10. Britton D.J., Hutcheson I.R., Knowlden J.M., Barrow D., Giles M., McClelland R.A., Gee J.M., Nicholson R.I. Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res. Treat. 2006, 96:131-146.
11. Bynote K.K., Hackenberg J.M., Korach K.S., Lubahn D.B., Lane P.H., Gould K.A. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB×NZW)F1 mice. Genes Immun. 2008, 9:137-152.
12. Carlsten H., Holmdahl R., Tarkowski A., Nilsson L.A. Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology 1989, 68:209-214.
13. Carreras E., Turner S., Paharkova-Vatchkova V., Mao A., Dascher C., Kovats S. Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation. J. Immunol. 2008, 180:727-738.
14. Carroll V.M., Jeyakumar M., Carlson K.E., Katzenellenbogen J.A. Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor beta-selective ligands. J. Med. Chem. 2012, 55:528-537.
15. Caulin-Glaser T., Watson C.A., Pardi R., Bender J.R. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J. Clin. Invest. 1996, 98:36-42.
16. Cavallini A., Messa C., Pricci M., Caruso M.L., Barone M., Di Leo A. Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer. Dig. Dis. Sci. 2002, 47:2720-2728.
17. Chambliss K.L., Yuhanna I.S., Anderson R.G., Mendelsohn M.E., Shaul P.W. ERbeta has nongenomic action in caveolae. Mol. Endocrinol. 2002, 16:938-946.
18. Chen J.Q., Delannoy M., Cooke C., Yager J.D. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am. J. Physiol. Endocrinol. Metab. 2004, 286. E1011-22.
19. Cheng G., Weihua Z., Warner M., Gustafsson J.A. Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland. Proc. Natl. Acad. Sci. USA 2004, 101:3739-3746.
20. Cheng J., Lee E.J., Madison L.D., Lazennec G. Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett. 2004, 566:169-172.
21. Cheng G., Li Y., Omoto Y., Wang Y., Berg T., Nord M., Vihko P., Warner M., Piao Y.S., Gustafsson J.A. Differential regulation of estrogen receptor (ER)alpha and ERbeta in primate mammary gland. J. Clin. Endocrinol. Metab. 2005, 90:435-444.
22. Choi K.C., Kang S.K., Tai C.J., Auersperg N., Leung P.C. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology 2001, 142:2351-2360.
23. Cignarella A., Bolego C., Pelosi V., Meda C., Krust A., Pinna C., Gaion R.M., Vegeto E., Maggi A. Distinct roles of estrogen receptor-alpha and beta in the modulation of vascular inducible nitric-oxide synthase in diabetes. J. Pharmacol. Exp. Ther. 2009, 328:174-182.
24. Collins F., MacPherson S., Brown P., Bombail V., Williams A.R., Anderson R.A., Jabbour H.N., Saunders P.T. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha. BMC Cancer 2009, 9:330.
25. Cowley S.M., Parker M.G. A comparison of transcriptional activation by ER alpha and ER beta. J. Steroid. Biochem. Mol. Biol. 1999, 69:165-175.
26. Curran E.M., Berghaus L.J., Vernetti N.J., Saporita A.J., Lubahn D.B., Estes D.M. Natural killer cells express estrogen receptor-alpha and estrogen receptor-beta and can respond to estrogen via a non-estrogen receptor-alpha-mediated pathway. Cell Immunol. 2001, 214:12-20.
27. Cutolo M., Capellino S., Montagna P., Ghiorzo P., Sulli A., Villaggio B. Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Res. Ther. 2005, 7. R1124-32.
28. Delpy L., Douin-Echinard V., Garidou L., Bruand C., Saoudi A., Guery J.C. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J. Immunol. 2005, 175:5050-5057.
29. Dey P., Jonsson P., Hartman J., Williams C., Strom A., Gustafsson J.A. Estrogen receptors beta1 and beta2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. Mol. Endocrinol. 2012, 26:1991-2003.
30. Dong W., Li J., Huang Y., Zhang H., Shan Z., Teng W. Differential expression patterns of estrogen receptor (ER)-beta splice variants between papillary thyroid cancer and nodular thyroid goiter. Med. Sci. Monit. 2012, 18. BR351-5.
31. Engdahl C., Jochems C., Windahl S.H., Borjesson A.E., Ohlsson C., Carlsten H., Lagerquist M.K. Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. Arthritis Rheum. 2010, 62:524-533.
32. Enmark E., Pelto-Huikko M., Grandien K., Lagercrantz S., Lagercrantz J., Fried G., Nordenskjold M., Gustafsson J.A. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 1997, 82:4258-4265.
33. Erlandsson M.C., Ohlsson C., Gustafsson J.A., Carlsten H. Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 2001, 103:17-25.
34. Erlandsson M.C., Jonsson C.A., Islander U., Ohlsson C., Carlsten H. Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology 2003, 108:346-351.
35. Esslimani-Sahla M., Kramar A., Simony-Lafontaine J., Warner M., Gustafsson J.A., Rochefort H. Increased estrogen receptor betacx expression during mammary carcinogenesis. Clin. Cancer Res. 2005, 11:3170-3174.
36. Forsythe A., Breland T., Majumdar S., Elkin T.D., Johnson D., Megason G. Gender differences in incidence rates of childhood B-precursor acute lymphocytic leukemia in Mississippi. J. Pediatr. Oncol. Nurs. : Off. J. Assoc. Pediatr. Oncol. Nurs. 2010, 27:164-167.
37. Forsythe A., Breland T., Majumdar S., Elkin T.D., Johnson D., Megason G. Gender differences in incidence rates of childhood B-precursor acute lymphocytic leukemia in Mississippi. J. Pediatr. Oncol. Nurs. 2010, 27:164-167.
38. Fox E.M., Davis R.J., Shupnik M.A. ERbeta in breast cancer-onlooker, passive player, or active protector?. Steroids 2008, 73:1039-1051.
39. Fujimoto J., Hori M., Ichigo S., Tamaya T. Ovarian steroids regulate the expression of basic fibroblast growth factor and its mRNA in fibroblasts derived from uterine endometrium. Ann. Clin. Biochem. 1997, 34(Pt 1):91-96.
40. Giroux V., Bernatchez G., Carrier J.C. Chemopreventive effect of ERbeta-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice. Mol. Carcinog. 2011, 50:359-369.
41. Grober O.M., Mutarelli M., Giurato G., Ravo M., Cicatiello L., De Filippo M.R., Ferraro L., Nassa G., Papa M.F., Paris O., Tarallo R., Luo S., Schroth G.P., Benes V., Weisz A. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genom. 2011, 12:36.
42. Hall J.M., McDonnell D.P. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999, 140:5566-5578.
43. Haring J., Skrzypczak M., Stegerer A., Lattrich C., Weber F., Gorse R., Ortmann O., Treeck O. Estrogen receptor beta transcript variants associate with oncogene expression in endometrial cancer. Int. J. Mol. Med. 2012, 29:1127-1136.
44. Harkonen P.L., Vaananen H.K. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann. NY Acad. Sci. 2006, 1089:218-227.
45. Hartman J., Lindberg K., Morani A., Inzunza J., Strom A., Gustafsson J.A. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res. 2006, 66:11207-11213.
46. Hartman J., Edvardsson K., Lindberg K., Zhao C., Williams C., Strom A., Gustafsson J.A. Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res. 2009, 69:6100-6106.
47. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87:905-931.
48. Helguero L.A., Faulds M.H., Gustafsson J.A., Haldosen L.A. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 2005, 24:6605-6616.
49. Henderson T.A., Saunders P.T., Moffett-King A., Groome N.P., Critchley H.O. Steroid receptor expression in uterine natural killer cells. J. Clin. Endocrinol. Metab. 2003, 88:440-449.
50. Hill L., Jeganathan V., Chinnasamy P., Grimaldi C., Diamond B. Differential roles of estrogen receptors alpha and beta in control of B-cell maturation and selection. Mol. Med. 2011, 17:211-220.
51. Huber J.C., Schneeberger C., Tempfer C.B. Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 2002, 42:1-12.
52. Imamov O., Morani A., Shim G.J., Omoto Y., Thulin-Andersson C., Warner M., Gustafsson J.A. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl. Acad. Sci. USA 2004, 101:9375-9380.
53. Jamadar-Shroff V., Papich M.G., Suter S.E. Soy-derived isoflavones inhibit the growth of canine lymphoid cell lines. Clin. Cancer Res. 2009, 15:1269-1276.
54. Jenkins J.K., Suwannaroj S., Elbourne K.B., Ndebele K., McMurray R.W. 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A. Int. Immunopharmacol. 2001, 1:1897-1911.
55. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 2000, 275:18447-18453.
56. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002, 3:221-227.
57. Kauss M.A., Reiterer G., Bunaciu R.P., Yen A. Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation. Exp. Cell Res. 2008, 314:2999-3006.
58. Komi J., Lassila O. Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 2000, 95:2875-2882.
59. Kouro T., Medina K.L., Oritani K., Kincade P.W. Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood 2001, 97:2708-2715.
60. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 1996, 93:5925-5930.
61. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
62. Kumar V.L., Kumar S., Srivastava A., Kumar V. Observations on the presence of E domain variants of estrogen receptor-alpha in the breast tumors. J. Surg. Oncol. 2006, 94:332-337.
63. Lamote I., Meyer E., De Ketelaere A., Duchateau L., Burvenich C. Expression of the estrogen receptor in blood neutrophils of dairy cows during the periparturient period. Theriogenology 2006, 65:1082-1098.
64. Lee J.S., Bracci P.M., Holly E.A. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use. Am. J. Epidemiol. 2008, 168:278-288.
65. Leitman D.C., Paruthiyil S., Vivar O.I., Saunier E.F., Herber C.B., Cohen I., Tagliaferri M., Speed T.P. Regulation of specific target genes and biological responses by estrogen receptor subtype agonists. Curr. Opin. Pharmacol. 2010, 10:629-636.
66. Lelu K., Laffont S., Delpy L., Paulet P.E., Perinat T., Tschanz S.A., Pelletier L., Engelhardt B., Guery J.C. Estrogen receptor alpha signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J. Immunol. 2011, 187:2386-2393.
67. Leung Y.K., Lam H.M., Wu S., Song D., Levin L., Cheng L., Wu C.L., Ho S.M. Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocr. Relat. Cancer 2010, 17:675-689.
68. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 2005, 19:1951-1959.
69. Li J., McMurray R.W. Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice. Int. Immunopharmacol. 2006, 6:1413-1423.
70. Li H., Tu Z., An L., Qian Z., Achilefu S., Gu Y. Inhibitory effects of ERbeta on proliferation, invasion, and tumor formation of MCF-7 breast cancer cells-prognostication for the use of ERbeta-selective therapy. Pharm. Biol. 2012, 50:839-849.
71. Lin C.Y., Vega V.B., Thomsen J.S., Zhang T., Kong S.L., Xie M., Chiu K.P., Lipovich L., Barnett D.H., Stossi F., Yeo A., George J., Kuznetsov V.A., Lee Y.K., Charn T.H., Palanisamy N., Miller L.D., Cheung E., Katzenellenbogen B.S., Ruan Y., Bourque G., Wei C.L., Liu E.T. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 2007, 3:e87.
72. Lin S.L., Yan L.Y., Zhang X.T., Yuan J., Li M., Qiao J., Wang Z.Y., Sun Q.Y. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways. PLoS ONE 2010, 5:e9013.
73. Mancuso M., Leonardi S., Giardullo P., Pasquali E., Borra F., Stefano I.D., Prisco M.G., Tanori M., Scambia G., Majo V.D., Pazzaglia S., Saran A., Gallo D. The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways. Cancer Lett. 2011, 308:197-202.
74. Mao A., Paharkova-Vatchkova V., Hardy J., Miller M.M., Kovats S. Estrogen selectively promotes the differentiation of dendritic cells with characteristics of Langerhans cells. J. Immunol. 2005, 175:5146-5151.
75. Maret A., Coudert J.D., Garidou L., Foucras G., Gourdy P., Krust A., Dupont S., Chambon P., Druet P., Bayard F., Guery J.C. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur. J. Immunol. 2003, 33:512-521.
76. Marotti T., Sirotkovic M., Pavelic J., Gabrilovac J., Pavelic K. In vivo effect of progesteron and estrogen on thymus mass and T-cell functions in female mice. Horm. Metab. Res. 1984, 16:201-203.
77. Marzioni M., Torrice A., Saccomanno S., Rychlicki C., Agostinelli L., Pierantonelli I., Rhonnstad P., Trozzi L., Apelqvist T., Gentile R., Candelaresi C., Fava G., Semeraro R., Benedetti A., Gaudio E., Franchitto A., Onori P., De Minicis S., Carpino G., Kallin E., Alvaro D., Nilsson S. An oestrogen receptor beta-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. Dig. Liver Dis. 2012, 44:134-142.
78. Masuzawa T., Miyaura C., Onoe Y., Kusano K., Ohta H., Nozawa S., Suda T. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J. Clin. Invest. 1994, 94:1090-1097.
79. Meyers M.J., Sun J., Carlson K.E., Marriner G.A., Katzenellenbogen B.S., Katzenellenbogen J.A. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J. Med. Chem. 2001, 44:4230-4251.
80. Minutolo F., Macchia M., Katzenellenbogen B.S., Katzenellenbogen J.A. Estrogen receptor beta ligands: recent advances and biomedical applications. Med. Res. Rev. 2011, 31:364-442.
81. Mohler M.L., Narayanan R., Coss C.C., Hu K., He Y., Wu Z., Hong S.S., Hwang D.J., Miller D.D., Dalton J.T. Estrogen receptor beta selective nonsteroidal estrogens: seeking clinical indications. Expert Opin. Ther. Pat. 2010, 20:507-534.
82. Mor G., Sapi E., Abrahams V.M., Rutherford T., Song J., Hao X.Y., Muzaffar S., Kohen F. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J. Immunol. 2003, 170:114-122.
83. Morales L.B., Loo K.K., Liu H.B., Peterson C., Tiwari-Woodruff S., Voskuhl R.R. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J. Neurosci. 2006, 26:6823-6833.
84. Morani A., Barros R.P., Imamov O., Hultenby K., Arner A., Warner M., Gustafsson J.A. Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice. Proc. Natl. Acad. Sci. USA 2006, 103:7165-7169.
85. Morton L.M., Wang S.S., Devesa S.S., Hartge P., Weisenburger D.D., Linet M.S. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006, 107:265-276.
86. Motylewska E., Stasikowska O., Melen-Mucha G. The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line. Cancer Lett. 2009, 276:68-73.
87. Mukherjee T.K., Nathan L., Dinh H., Reddy S.T., Chaudhuri G. 17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. J. Biol. Chem. 2003, 278:11746-11752.
88. Nakajima Y., Akaogi K., Suzuki T., Osakabe A., Yamaguchi C., Sunahara N., Ishida J., Kako K., Ogawa S., Fujimura T., Homma Y., Fukamizu A., Murayama A., Kimura K., Inoue S., Yanagisawa J. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5. Sci. Signal 2011, 4:ra22.
89. Nalbandian G., Paharkova-Vatchkova V., Mao A., Nale S., Kovats S. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. J. Immunol. 2005, 175:2666-2675.
90. Nelson R.A., Levine A.M., Bernstein L. Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women. J. Clin. Oncol. 2001, 19:1381-1387.
91. Nilsen J., Mor G., Naftolin F. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J. Neurobiol. 2000, 43:64-78.
92. Nilsson S., Koehler K.F. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology. Basic Clin. Pharmacol. Toxicol. 2005, 96:15-25.
93. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 2001, 81:1535-1565.
94. Omoto Y., Eguchi H., Yamamoto-Yamaguchi Y., Hayashi S. Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7. Oncogene 2003, 22:5011-5020.
95. Omoto Y., Imamov O., Warner M., Gustafsson J.A. Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen. Proc. Natl. Acad. Sci. USA 2005, 102:1484-1489.
96. Paharkova-Vatchkova V., Maldonado R., Kovats S. Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors. J. Immunol. 2004, 172:1426-1436.
97. Parkin D.M., Stiller C.A., Draper G.J., Bieber C.A. The international incidence of childhood cancer. Int. J. Cancer 1988, 42:511-520.
98. Paruthiyil S., Parmar H., Kerekatte V., Cunha G.R., Firestone G.L., Leitman D.C. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 2004, 64:423-428.
99. Paruthiyil S., Cvoro A., Zhao X., Wu Z., Sui Y., Staub R.E., Baggett S., Herber C.B., Griffin C., Tagliaferri M., Harris H.A., Cohen I., Bjeldanes L.F., Speed T.P., Schaufele F., Leitman D.C. Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists. PLoS ONE 2009, 4:e6271.
100. Patten R.D., Pourati I., Aronovitz M.J., Baur J., Celestin F., Chen X., Michael A., Haq S., Nuedling S., Grohe C., Force T., Mendelsohn M.E., Karas R.H. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ. Res. 2004, 95:692-699.
101. Pedram A., Razandi M., Aitkenhead M., Levin E.R. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J. Biol. Chem. 2005, 280:26339-26348.
102. Pedram A., Razandi M., O'Mahony F., Lubahn D., Levin E.R. Estrogen receptor-beta prevents cardiac fibrosis. Mol. Endocrinol. 2010, 24:2152-2165.
103. Pelzer T., Neumann M., de Jager T., Jazbutyte V., Neyses L. Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta. Biochem. Biophys. Res. Commun. 2001, 286:1153-1157.
104. Peng B., Lu B., Leygue E., Murphy L.C. Putative functional characteristics of human estrogen receptor-beta isoforms. J. Mol. Endocrinol. 2003, 30:13-29.
105. Pennell L.M., Galligan C.L., Fish E.N. Sex affects immunity. J. Autoimmun. 2012, 38. J282-91.
106. Perillo B., Sasso A., Abbondanza C., Palumbo G. 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell Biol. 2000, 20:2890-2901.
107. Phiel K.L., Henderson R.A., Adelman S.J., Elloso M.M. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol. Lett. 2005, 97:107-113.
108. Polanczyk M.J., Carson B.D., Subramanian S., Afentoulis M., Vandenbark A.A., Ziegler S.F., Offner H. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J. Immunol. 2004, 173:2227-2230.
109. Poola I., Speirs V. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J. Steroid. Biochem. Mol. Biol. 2001, 78:459-469.
110. Powell E., Xu W. Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers. Proc. Natl. Acad. Sci. USA 2008, 105:19012-19017.
111. Prins G.S., Korach K.S. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008, 73:233-244.
112. Razandi M., Alton G., Pedram A., Ghonshani S., Webb P., Levin E.R. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol. Cell Biol. 2003, 23:1633-1646.
113. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
114. Rijhsinghani A.G., Thompson K., Bhatia S.K., Waldschmidt T.J. Estrogen blocks early T cell development in the thymus. Am. J. Reprod. Immunol. 1996, 36:269-277.
115. Salem M.L. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr. Drug Targets Inflamm. Allergy 2004, 3:97-104.
116. Sanchez Y., Amran D., de Blas E., Aller P. Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) Protein kinase modulation and reactive oxygen species generation. Biochem. Pharmacol. 2009, 77:384-396.
117. Sapi E., Brown W.D., Aschkenazi S., Lim C., Munoz A., Kacinski B.M., Rutherford T., Mor G. Regulation of Fas ligand expression by estrogen in normal ovary. J. Soc. Gynecol. Investig. 2002, 9:243-250.
118. Sato T., Ito A., Mori Y., Yamashita K., Hayakawa T., Nagase H. Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Biochem. J. 1991, 275(Pt 3):645-650.
119. Seillet C., Laffont S., Tremollieres F., Rouquie N., Ribot C., Arnal J.F., Douin-Echinard V., Gourdy P., Guery J.C. The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor signaling. Blood 2012, 119:454-464.
120. Shaaban A.M., Green A.R., Karthik S., Alizadeh Y., Hughes T.A., Harkins L., Ellis I.O., Robertson J.F., Paish E.C., Saunders P.T., Groome N.P., Speirs V. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clin. Cancer Res. 2008, 14:5228-5235.
121. Shim G.J., Wang L., Andersson S., Nagy N., Kis L.L., Zhang Q., Makela S., Warner M., Gustafsson J.A. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. USA 2003, 100:6694-6699.
122. Shim G.J., Kis L.L., Warner M., Gustafsson J.A. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc. Natl. Acad. Sci. USA 2004, 101:1720-1724.
123. Shim G.J., Gherman D., Kim H.J., Omoto Y., Iwase H., Bouton D., Kis L.L., Andersson C.T., Warner M., Gustafsson J.A. Differential expression of oestrogen receptors in human secondary lymphoid tissues. J. Pathol. 2006, 208:408-414.
124. Siracusa M.C., Overstreet M.G., Housseau F., Scott A.L., Klein S.L. 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. J. Immunol. 2008, 180:1423-1431.
125. Sotoca A.M., van den Berg H., Vervoort J., van der Saag P., Strom A., Gustafsson J.A., Rietjens I., Murk A.J. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells. Toxicol. Sci. 2008, 105:303-311.
126. Stauffer S.R., Coletta C.J., Tedesco R., Nishiguchi G., Carlson K., Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J. Med. Chem. 2000, 43:4934-4947.
127. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28:521-574.
128. Strom A., Hartman J., Foster J.S., Kietz S., Wimalasena J., Gustafsson J.A. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl. Acad. Sci. USA 2004, 101:1566-1571.
129. Stygar D., Westlund P., Eriksson H., Sahlin L. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes. Clin. Endocrinol. (Oxf) 2006, 64:74-81.
130. Sunyer T., Lewis J., Collin-Osdoby P., Osdoby P. Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J. Clin. Invest. 1999, 103:1409-1418.
131. Svenson J.L., EuDaly J., Ruiz P., Korach K.S., Gilkeson G.S. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin. Immunol. 2008, 128:259-268.
132. Takao T., Kumagai C., Hisakawa N., Matsumoto R., Hashimoto K. Effect of 17beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes. J. Endocrinol. 2005, 184:191-197.
133. Talal N. Sex hormones and modulation of immune response in SLE. Clin. Rheum. Dis. 1982, 8:23-28.
134. Taylor S.E., Martin-Hirsch P.L., Martin F.L. Oestrogen receptor splice variants in the pathogenesis of disease. Cancer Lett. 2010, 288:133-148.
135. Thomas C., Gustafsson J.A. The different roles of ER subtypes in cancer biology and therapy. Nat. Rev. Cancer 2011, 11:597-608.
136. Tu Z., Ma Y., Tian J., Li H., Akers W., Achilefu S., Gu Y. Estrogen receptor beta potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells. J. Cancer Res. Clin. Oncol. 2012, 138:1091-1103.
137. Wada-Hiraike O., Hiraike H., Okinaga H., Imamov O., Barros R.P., Morani A., Omoto Y., Warner M., Gustafsson J.A. Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta-/- mice. Proc. Natl. Acad. Sci. USA 2006, 103:18350-18355.
138. Wada-Hiraike O., Imamov O., Hiraike H., Hultenby K., Schwend T., Omoto Y., Warner M., Gustafsson J.A. Role of estrogen receptor beta in colonic epithelium. Proc. Natl. Acad. Sci. USA 2006, 103:2959-2964.
139. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. USA 2006, 103:9063-9068.
140. Wen Y., Yang S., Liu R., Perez E., Yi K.D., Koulen P., Simpkins J.W. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res. 2004, 1008:147-154.
141. Williams C., Edvardsson K., Lewandowski S.A., Strom A., Gustafsson J.A. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 2008, 27:1019-1032.
142. Wilson C.A., Mrose S.A., Thomas D.W. Enhanced production of B lymphocytes after castration. Blood 1995, 85:1535-1539.
143. Witek A., Paul-Samojedny M., Stojko R., Seifert B., Mazurek U. Coexpression index of estrogen receptor alpha mRNA isoforms in simple, complex hyperplasia without atypia, complex atypical hyperplasia and adenocarcinoma. Gynecol. Oncol. 2007, 106:407-412.
144. Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012, 18:1028-1040.
145. Xiu-li W., Wen-jun C., Hui-hua D., Su-ping H., Shi-long F. ERB-041, a selective ER beta agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-kappaB activation. Mol. Immunol. 2009, 46:2413-2418.
146. Yakimchuk K., Iravani M., Hasni M.S., Rhonnstad P., Nilsson S., Jondal M., Okret S. Effect of ligand-activated estrogen receptor beta on lymphoma growth in vitro and in vivo. Leukemia 2011, 25:1103-1110.
147. Yakimchuk K., Norin S., Kimby E., Hagglund H., Warner M., Gustafsson J.A. Up-regulated estrogen receptor beta2 in chronic lymphocytic leukemia. Leuk. Lymphoma. 2012, 53:139-144.
148. Yamasaki M., Mukai A., Ohba M., Mine Y., Sakakibara Y., Suiko M., Morishita K., Nishiyama K. Genistein induced apoptotic cell death in adult T-cell leukemia cells through estrogen receptors. Biosci. Biotechnol. Biochem. 2010, 74:2113-2115.
149. Yasuda M., Shimizu I., Shiba M., Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999, 29:719-727.
150. Zhao C., Gao H., Liu Y., Papoutsi Z., Jaffrey S., Gustafsson J.A., Dahlman-Wright K. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res. 2010, 70:5174-5183.
151. Zhou Y., Shimizu I., Lu G., Itonaga M., Okamura Y., Shono M., Honda H., Inoue S., Muramatsu M., Ito S. Hepatic stellate cells contain the functional estrogen receptor beta but not the estrogen receptor alpha in male and female rats. Biochem. Biophys. Res. Commun. 2001, 286:1059-1065.